Cargando…

Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells

Despite the progressive research and recent advances in drug therapy to treat solid tumours, the number of cases and deaths in patients with cancer is still a major health problem. Drug repurposing coupled to drug combination strategies has been gaining interest among the scientific community. Recen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duarte, Diana, Rêma, Alexandra, Amorim, Irina, Vale, Nuno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961626/ https://www.ncbi.nlm.nih.gov/pubmed/35204691 http://dx.doi.org/10.3390/biom12020190

Ejemplares similares

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Novel Strategies for Cancer Combat: Drug Combination Using Repurposed Drugs Induces Synergistic Growth Inhibition of MCF-7 Breast and HT-29 Colon Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)

Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
por: Rodrigues, Rafaela, et al.
Publicado: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen
por: Kast, Richard E, et al.
Publicado: (2017)

Repurposing of the Drug Tezosentan for Cancer Therapy
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

The Role of Dopamine in Repurposing Drugs for Oncology
por: Moura, Catarina, et al.
Publicado: (2023)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

In Vitro Drug Repurposing: Focus on Vasodilators
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
por: Lourenço, Tânia, et al.
Publicado: (2023)

Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines
por: Duarte, Diana, et al.
Publicado: (2021)

Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs
por: Duarte, Diana, et al.
Publicado: (2021)

Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
por: El Zarif, Talal, et al.
Publicado: (2022)

Exploring the Role of Drug Repurposing in Bridging the Hypoxia–Depression Connection
por: Correia, Ana Salomé, et al.
Publicado: (2023)

Evaluation of synergism in drug combinations and reference models for future orientations in oncology
por: Duarte, Diana, et al.
Publicado: (2022)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
por: Costa, Bárbara, et al.
Publicado: (2021)

Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action
por: Duarte, Diana, et al.
Publicado: (2022)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Drug-Repurposing Strategy for Dimethyl Fumarate
por: Giunta, Salvatore, et al.
Publicado: (2023)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

Drug repurposing: An effective strategy to accelerate contemporary drug discovery
por: Zhan, Peng, et al.
Publicado: (2022)

Antidepressant Drug Sertraline against Human Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)

Antipsychotic Drug Fluphenazine against Human Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

Strategies for drug repurposing against coronavirus targets
por: Smith, Poppy O., et al.
Publicado: (2021)

Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

The importance of epithelial-mesenchymal transition and autophagy in cancer drug resistance
por: Hill, Charlotte, et al.
Publicado: (2020)

Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis
por: Lim, Jin Hong, et al.
Publicado: (2020)

New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2020)

NSAIDs as a Drug Repurposing Strategy for Biofilm Control
por: Leão, Cláudia, et al.
Publicado: (2020)

Drug repurposing strategies in the development of potential antifungal agents
por: Zhang, Qian, et al.
Publicado: (2021)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

PRP4 Induces Epithelial–Mesenchymal Transition and Drug Resistance in Colon Cancer Cells via Activation of p53
por: Islam, Salman Ul, et al.
Publicado: (2022)

Drug repurposing strategy II: from approved drugs to agri-fungicide leads
por: An, Jun-Xia, et al.
Publicado: (2023)

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
por: Du, Bowen, et al.
Publicado: (2016)

Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
por: Busuioc, Constantin, et al.
Publicado: (2021)

Study of New Therapeutic Strategies to Combat Breast Cancer Using Drug Combinations
por: Correia, Ana, et al.
Publicado: (2018)

Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition
por: Davis, Joshua T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_33moub9cdl856uggdcbtgps8b7